A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy

被引:34
|
作者
Chen, Yan [1 ]
Wu, Liwen [1 ]
Fang, Yue [2 ]
He, Zhiyi [3 ]
Peng, Bingwei [1 ]
Shen, Yan [2 ]
Xu, Qi [2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China
[3] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China
关键词
Nocturnal frontal lobe epilepsy; Mutation; CHRNA4; SUBUNIT; ETHANOL; FAMILY; SLEEP; CLASSIFICATION; POLYMORPHISM; SEIZURES; BETA-2;
D O I
10.1016/j.eplepsyres.2008.10.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is known to be partly caused by mutations in the transmembrane domain (TM) 1-3 of the genes of the neuronal nicotinic acetylcholine receptor (nAChR) alpha 4-subunit (CHRNA4), beta 2-subunit (CHRNB2) and alpha 2-subunit (CHRNA2). The more common cases of sporadic nocturnal frontal lobe epilepsy (NFLE) that are not differentiated from ADNFLE by phenotype have been found to be associated with the mutation of CHRNA4 reported in ADNFLE. In order to assess the genetic defects in NFLE, we performed a mutation screening in 33 unrelated patients with sporadic NFLE by amplifying and sequencing bidirectionally TM 1-3 of CHRNA4, CHRNB2 and CHRNA2 which contain the mutations reported in ADNFLE. In screening CHRNA4, we identified a novel mutation in one patient that causes a alpha 4-R308H amino acid exchange outside the TM, and in the second intracellular loop between the third and fourth transmembrane domains. The mutation was not observed in 400 control chromosomes. No mutations were present in parts of CHRNB2 and CHRNA2. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 156
页数:5
相关论文
共 50 条
  • [21] Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry
    Indurthi, Dinesh C.
    Qudah, Taima
    Liao, Vivian W.
    Ahring, Philip K.
    Lewis, Trevor M.
    Balle, Thomas
    Chebib, Mary
    Absalom, Nathan L.
    PHARMACOLOGICAL RESEARCH, 2019, 139 : 215 - 227
  • [22] The association between the nicotinic acetylcholine receptor α4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults
    Jeong, Jo-Eun
    Rhee, Je-Keun
    Kim, Tae-Min
    Kwak, Su-Min
    Bang, Sol-hee
    Cho, Hyun
    Cheon, Young-Hoon
    Min, Jung Ah
    Yoo, Gil Sang
    Kim, Kyudong
    Choi, Jung-Seok
    Choi, Sam-Wook
    Kim, Dai-Jin
    PLOS ONE, 2017, 12 (12):
  • [23] Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease
    Steinlein, OK
    Stoodt, J
    de Vos, RAI
    Steur, ENHJ
    Wevers, A
    Schütz, U
    Schröder, H
    NEUROREPORT, 1999, 10 (14) : 2919 - 2922
  • [24] Possible Association of Nicotinic Acetylcholine Receptor Gene (CHRNA4 and CHRNB2) Polymorphisms with Nicotine Dependence in Japanese Males: An Exploratory Study
    Chen, H. -I.
    Shinkai, T.
    Utsunomiya, K.
    Yamada, K.
    Sakata, S.
    Fukunaka, Y.
    Hwang, R.
    De Luca, V.
    Ohmori, O.
    Kennedy, J. L.
    Chuang, H. -Y.
    Nakamura, J.
    PHARMACOPSYCHIATRY, 2013, 46 (02) : 77 - 82
  • [25] Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease
    Cook, LJ
    Ho, LW
    Taylor, AE
    Brayne, C
    Evans, JG
    Xuereb, J
    Cairns, NJ
    Pritchard, A
    Lemmon, H
    Mann, D
    Clair, DS
    Turic, D
    Hollingworth, P
    Moore, PJ
    Jehu, L
    Archer, N
    Walter, S
    Foy, C
    Edmondson, A
    Powell, J
    Lovestone, S
    Owen, MJ
    Williams, J
    Lendon, C
    Rubinsztein, DC
    NEUROSCIENCE LETTERS, 2004, 358 (02) : 142 - 146
  • [26] Association of polymorphisms in nicotinic acetylcholine receptor α4 subunit gene (CHRNA4), μ-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients
    Kim, SA
    Kim, JW
    Song, JY
    Park, S
    Lee, HJ
    Chung, JH
    ALCOHOL, 2004, 34 (2-3) : 115 - 120
  • [27] Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor α4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes
    Matsushima, N
    Hirose, S
    Iwata, H
    Fukuma, G
    Yonetani, M
    Nagayama, C
    Hamanaka, W
    Matsunaka, Y
    Ito, M
    Kaneko, S
    Mitsudome, A
    Sugiyama, H
    EPILEPSY RESEARCH, 2002, 48 (03) : 181 - 186
  • [28] Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression
    Nichols, Weston A.
    Henderson, Brandon J.
    Marotta, Christopher B.
    Yu, Caroline Y.
    Richards, Chris
    Dougherty, Dennis A.
    Lester, Henry A.
    Cohen, Bruce N.
    PLOS ONE, 2016, 11 (06):
  • [29] Nocturnal frontal lobe epilepsy caused by a mutation in the GATOR1 complex gene NPRL3
    Korenke, Georg-Christoph
    Eggert, Marlene
    Thiele, Holger
    Nuernberg, Peter
    Sander, Thomas
    Steinlein, Ortrud K.
    EPILEPSIA, 2016, 57 (03) : E60 - E63
  • [30] Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the β2 nicotinic receptor
    Xu, J.
    Cohen, B. N.
    Zhu, Y.
    Dziewczapolski, G.
    Panda, S.
    Lester, H. A.
    Heinemann, S. F.
    Contractor, A.
    MOLECULAR PSYCHIATRY, 2011, 16 (10) : 1048 - 1061